45
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Regulation of platelet adhesion by oxidized lipoproteins and oxidized phospholipids

, , , , , , , , , & show all
Pages 141-151 | Published online: 07 Jul 2009

  • Ross R. Mechanisms of disease: Atherosclerosis: an inflammatory disease. New Engl J Med 1999; 340: 115-26.
  • Krauss RM, Williams PT, Lingren FT, Wood PD. Coordinate changes in levels of human serum low and high-density lipoprotein subclass in healthy men. Atherosclerosis 1988; 8: 155-62.
  • Hodis HN, Mack WJ. Triglyceride-rich lipoproteins and progression of atherosclerosis. Eur Heart J 1998; Suppl. 19: A40-4.
  • Langmann T, Klucken J, Reil M, Liebisch G, Luciani MF, Chimini G, Kaminski WE, Schmitz G. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for steroldependent regulation in macrophages. Biochem Biophys Res Commun 1999; 257: 29-33.
  • Dunn RC, Schachter M, Miles CM, Feher MD, Tranter PR, Bruckdofer KR, Sever PS. Low-density lipoproteins increase intracellular calcium in aequorin-loaded platelets. FEBS Lett 1988; 238: 357-60.
  • Desai K, Bruckdorfer KR, Hutton RA, Owen JS. Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation. J Lipid Res 1989; 30: 831-40.
  • Watkins SM, German JB, Shoenfeld Y, Gershwin ME. Lipids and immunity. In: Shoenfeld Y, Harrats D, Wick G, ed. Atherosclerosis and Autoimmunity. Amsterdam: Elsevier, 2001: 87-111.
  • Inoue N, Takeshita S, Gao D, Ishida T, Kawashima S, Akita H, Tawa R, Sakurai H, Yokoyama M. Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis 2001; 155: 45-52.
  • Hansson GK, Nicoletti A. Autoimmune aspects of atherosclerosis. In: Shoenfeld Y, Harrats D, Wick G, ed. Atherosclerosis and Autoimmunity. Amsterdam: Elsevier, 2001: 17-26.
  • Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, Navab M. Protective effect of high density lipoprotein associated paraoxonase. J Clin Invest 1995; 96: 2882-91.
  • Berliner J, Leitinger N, Watson AD, Huber J, Fogelman A, Navab M. Oxidized lipids in atherogenesis; formation, destruction and action. Thromb Haemost 1997; 78: 195-9.
  • Leitinger N, Watson AD, Hama SY, Ivandic B, Qiao JH, Huber J, Faull KF, Grass DS, Navab M, Fogelman AM, de Beer FC, Lusis AJ, Berliner JA. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids. Arterioscler Thromb Wise Biol 1999; 19: 1291-8.
  • Watson AD, Leitinger N, Navab M, Faull KF, Hörkö S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 1997; 272: 13597-607.
  • Itabe H, Yamamoto H, Suzuki M, Kawai Y, Nakagawa Y, Suzuki A, Imanaka T, Takano T. Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein. J Biol Chem 1996; 271: 33208-17.
  • Vaarala O, Mänttäri M, Manninen V, Tenkanen L, Puurunen M, Aho K, Palosuo T. Anti-cardiolipin antibodies and risk of myocardial infarction in an prospective cohort of middle-aged men. Circulation 1995; 91: 23-7.
  • Vaarala O. Autoimmune risk factors of atherothrombosis. In: Zanussi C, Meroni PL, Giridi G, eds. Seminars in Clinical Immunology. Milano: Edizioni Grafiche Mazzucchelli; 2000; 19: 15-20.
  • Leitinger M, Mechtcheriakova D, Gruber F, Huber J, Binder BR. Biologically active oxidized phospholipids induce tissue factor expression in endothelial cells via MAP-kinases and egr-1. J Submicrosc Cytol Pathol 2000; 32: Abstr. A125.
  • Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. / Clin Invest 1955; 23: 34-40.
  • Wallin B, Rosengren B, Shertzer HG, Camejo G. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate: its use for evaluation of antioxidants. Anal Biochem 1993; 208: 10-15.
  • Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-70.
  • Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, Santonastaso S. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994; 216: 444-50.
  • Schmitz G, Rothe G, Ruf A, Barlage S, Tschöpe D, Clemetson KJ, Goodall AH, Michelson AD, Nurden AT, Shankey TV. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 1998; 79: 885-96.
  • Michelson AD, Benoit SE, Kroll MH, Li JM, Rohrer MJ, Kestin AS, Barnard MR. The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible. Blood 1994; 83: 3562-73.
  • Kowalska MA, Tuszynski GP, Capuzzi DM. Plasma lipoproteins mediate platelet adhesion. Biochem Biophys Res Commun 1990; 172: 113-8.
  • Dembinska-Kiec A, BurchertM, Hartwich J, Gryglewski R, Peskar BA. A neutrophil-derived NO-synthase (NOS) inhibitor. Agents Actions 1995; 45: 163-8.
  • Israels SJ, Gerrard JM, Jacques YV, McNicol A, Cham B, Nishibori M, Bainton DF. Platelet dense granule membranes contain both granulophysin and P-selectin (GMP-140). Blood 1992; 80: 143-52.
  • Dembinska-Kiec A, Zmuda A, Wenhrynowicz O, Stachura J, Peskar BA, Gryglewski JR. Selectin-P. mediated adherence of platelets to neutrophils is regulated by prostanoids and nitric oxide. Int J Tiss React 1993; 15: 55-64.
  • Takahashi Y, Fuda H, Yanai H, Akita H, Shuping H, Chiba H, Matsuno K. Significance of membrane glycoproteins in platelet interaction with oxidized low-density lipoprotein. Semin Thromb Hemost 1998; 24: 251-3.
  • Tangirala RK, Pratico D, FitzGerald GA, Chun S, Tsukarnoto K, Maugeais C, Usher DC, Pure E, Rader DJ. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem 2001; 276: 261-6.
  • van Lenten BJ, Wagner AC, Navab M, Fogelman AM. Oxidized phospholipids induce changes in hepatic paraoxonase and apoJ but not monocyte chemoattractant protein-1 via interleukin-6. J Biol Chem 2001; 276: 1923-9.
  • Salvemini D, deNucci G, Sneddon JM, Vane JR. Superoxide anions enhance platelet adhesion and aggregation. Br J Pharmacol 1989; 97: 1145-50.
  • Nicholson AC, Han J, Febbraio M, Frieda S, Pearce A, Gotto A, Hajjar DP. CD36, the macrophage class B scavenger receptor: regulation and role in atherosclerosis. In: Shoenfeld Y, Harrats D, Wick G, eds. Atherosclerosis and Autoimmunity. Amsterdam: Elsevier, 2001; 41-8.
  • Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. Cloning of rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. J Biol Chem 1993; 268: 17665-8.
  • Parthasarathy S, Pong LG, Otero D, Steinberg D. Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor. Proc Natl Acad Sei USA 1987; 84: 537-40.
  • Nicholson AC, Frieda S, Pearce A, Silverstein RL. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vase Biol 1995; 15: 269-75.
  • Rigotti A, Acton SL, Krieger M. The class B scavenger receptors SR-B1 and CD36 are receptors for anionic phospholipids. J Biol Chem 1995; 270: 16221-4.
  • VoIf I, Moeslinger T, Cooper J, Schmid W, Koller E. Human platelets exclusively bind oxidized low density lipoprotein showing no specificity for acetylated low density lipoprotein. FEBS Lett 1999; 449: 141-5.
  • Reddy S, Hama S, Grijalva V, Hassan K, Mottahedeh R, Hough G, Wadleigh DJ, Navab M, Fogelman AM. Mitogen-activated kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells. J Biol Chem 2001; 276: 17030-5.
  • Keyse SM. Protein phosphatases and the regulation of mitogen-activated protein-kinase signalling. Curr Opin Cell Biol 2000; 12: 186-92,
  • Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998; 102: 136-44.
  • Balestrieri MR, Servillo L, Lee T. The role of platelet-activating factor-dependent transacetylase in the biosyntheses of 1-acyl-2-acetyl-fn-glycero-3-phosphocholine by stimulated endothelial cd\sJBiol Chem 1997; 272: 17431-7.
  • Podrez EA, Balyrova E, Shen Z, Deng Y, Febbraio M, Schmitt D, Silverstein RL, Salomon RG, Hoff HF, Hazan SL. Identification of structurally specific oxidized phospholipids as ligands for the macrophage scavenger receptor CD36. Arteriosclerosis 2001; 658 (Abstr No 84).
  • Mauco G, Artcanuthurry V, Pidard D, Grelac F, Maclouf J, Levy-Toledano S. Total inhibition of phospholipase C and phosphatidylinositol 3-kinase by okadaic acid in thrombin-stimulated platelets. Cell Signal 1997; 9: 117-24.
  • Chiang TM. Okadaic acid and vanadate inhibit collagen-induced platelet aggregation; the functional relation of phosphatases on platelet aggregation. Thromb Res 1992; 67: 345-54.
  • Kawakami H, Higashihara M, Song XH, Kurokawa K, Ikebe M, Hirano H. Okadaic acid induces marked shape changes of human platelets. / Smooth Muscle Res 1994; 30: 57-64.
  • Yano Y, Sakon M, Kambayashi J, Kawasaki T, Senda T, Tanaka K, Yamada F, Shibata N. Cytoskeletal reorganization of human platelets induced by the protein phosphatase 1/2A inhibitors okadaic acid and calyculin A. Biochem J 1995; 307: 439-49.
  • Daviet L, McGregor JL. Vascular biology of CD36: roles of this new adhesion molecule family in different disease states. Thromb Haemost 1997; 78: 65-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.